Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
---|
07/11/1996 | WO1996020690A2 3,3-(disubstituted)cyclohexan-1-ylidine acetate monomers and related compounds |
07/11/1996 | CA2209134A1 Tricyclic retinoids, methods for their production and use |
07/11/1996 | CA2184174A1 Novel thiazolidin-4-one derivatives |
07/10/1996 | EP0720622A1 Interaction of t-cell receptors and antigen in autoimmune disease |
07/10/1996 | EP0720619A1 Selectin binding glycopeptides |
07/10/1996 | EP0720598A1 Phenoxyphenyl cyclopentenyl hydroxyureas |
07/10/1996 | EP0720484A1 Methods and products for controlling immune responses in mammals |
07/10/1996 | EP0720481A1 Uses of vegetable oils |
07/10/1996 | EP0635012B1 Unbridged bis-aryl carbinol derivatives, compositions and methods of use |
07/10/1996 | EP0619818B1 Imidazoylalkyl substituted with a six membered nitrogen containing heterocyclic ring |
07/10/1996 | CN1126494A Method for recombinant production of biologically active polypeptides |
07/10/1996 | CN1126470A Pyridazinone derivatives with pharmaceutical activity |
07/10/1996 | CN1126469A HIV protease inhibitors useful for the treatment of aids |
07/10/1996 | CN1126468A Fluoroalkoxy-substituted benzamides and their use as cyclic nucleotide phosphodiesterase inhibitors |
07/10/1996 | CN1032253C Process for preparation of oxalylamino acid derivatives, and their use as medicaments for inhibiting proline hydroxylase |
07/09/1996 | US5534509 Pharmaceutical composition regulating function of a living body |
07/09/1996 | US5534256 Vaccines, veterinary medicine |
07/09/1996 | CA2099381C Imidazopyridine paf/h _antagonists |
07/04/1996 | WO1996020277A2 Recombinant monoclonal anti-idiotype antibody 3h1 sequences relating to human carcinoembryonic antigen |
07/04/1996 | WO1996020222A1 Novel cyclodextrin-derivatives and methods for the preparation thereof |
07/04/1996 | WO1996020219A2 Murine monoclonal anti-idiotype antibody 3h1 |
07/04/1996 | WO1996020216A1 Fibronectin adhesion inhibitors |
07/04/1996 | WO1996020215A2 Use of mhc-ii binding and/or mhc-ii mimicking molecules for the prevention and/or treatment of inflammatory diseases |
07/04/1996 | WO1996020162A1 1,4,4-(trisubstituted)cyclohex-1-ene dimers and related compounds |
07/04/1996 | WO1996020161A1 4,4-(disubstituted)cyclohexan-1-ol dimers and related compounds |
07/04/1996 | WO1996020160A1 1,3,3-(trisubstituted)cyclohexane dimers and related compounds |
07/04/1996 | WO1996020159A1 3,3-(disubstituted)cyclohexan-1-ylidine acetate monomers and related compounds |
07/04/1996 | WO1996020157A1 3,3-(disubstituted)cyclohexan-1-ol dimers and related compounds |
07/04/1996 | WO1996020156A1 3,3-(disubstituted)cyclohexan-1-carboxylate dimers and related compounds |
07/04/1996 | WO1996020153A1 4,4-(disubstituted)cyclohexan-1-one dimers and related compounds |
07/04/1996 | WO1996020008A1 Vaccine adjuvants |
07/04/1996 | WO1996019991A1 Benzimidazoles as inhibitors of calcitriol metabolism |
07/04/1996 | WO1996019990A1 4,4-(disubstituted)cyclohexan-1-carboxylate monomers and related compounds |
07/04/1996 | WO1996019985A1 3,3-(disubstituted)cyclohexan-1-ylidine acetate dimers and related compounds |
07/04/1996 | WO1996019984A1 4,4-(disubstituted)cyclohexan-1-ylidine acetate dimers and related compounds |
07/04/1996 | WO1996019983A1 4,4-(disubstituted)cyclohexan-1-ylidine acetate dimers and related compounds |
07/04/1996 | WO1996019980A1 3,3-(disubstituted)cyclohexan-1-one dimers and related compounds |
07/04/1996 | WO1996019979A1 1,4,4-(trisubstituted)cyclohexane dimers and related compounds |
07/04/1996 | WO1996019978A1 1,3,3-(trisubstituted)cyclohex-1-ene dimers and related compounds |
07/04/1996 | WO1996019977A1 3,3-(disubstituted)cyclohexan-1-ol monomers and related compounds |
07/04/1996 | WO1996019965A2 Engraftment of hematopoietic cells from a primate donor to a primate recipient |
07/04/1996 | CA2208719A1 Engraftment of hematopoietic cells from a primate donor to a primate recipient |
07/04/1996 | CA2208445A1 3,3-(disubstituted)cyclohexan-1-ol monomers and related compounds |
07/04/1996 | CA2208233A1 Use of mhc-ii binding and/or mhc-ii mimicking molecules for the prevention and/or treatment of inflammatory diseases |
07/04/1996 | CA2204793A1 Fibronectin adhesion inhibitors |
07/03/1996 | EP0719787A1 Dicarboxymethylated glycolipid derivatives as cell adhesion inhibitors |
07/03/1996 | EP0719558A1 Ranolazine and related piperazines for use in the treatment of shock conditions |
07/03/1996 | EP0719551A2 Isolating aminoarginine and use to block nitric oxide formation in body |
07/03/1996 | EP0719550A2 A method of inhibiting endotoxin induced effects |
07/03/1996 | EP0719549A1 Soft gelatine pharmaceutical dosage form containing a translucent gel |
07/03/1996 | EP0719548A1 Gelling agent for polyethylene glycol |
07/03/1996 | EP0719343A1 Adeno-associated viral (aav) liposomes and methods related thereto |
07/03/1996 | EP0719340A1 Cloned glutamic acid decarboxylase |
07/03/1996 | EP0719331A1 Eotaxin = eosinophil chemotactic cytokine |
07/03/1996 | EP0719328A1 Grb3-3 gene, variants and uses thereof |
07/03/1996 | EP0719295A1 Polymeric matrices and their uses in pharmaceutical compositions |
07/03/1996 | EP0719285A1 Il8 inhibitors |
07/03/1996 | EP0719267A1 Second messenger cell signaling inhibitors |
07/03/1996 | EP0719253A1 3-amino-5-carboxy-substituted piperidines and 3-amino-4-carboxy-substituted pyrrolidines as tachykinin antagonists |
07/03/1996 | EP0719150A1 Cellular vaccine and methods of use for the treatment of solid tumor malignancies |
07/03/1996 | EP0719142A1 Pharmaceutical composition of hiv-protease inhibitors |
07/03/1996 | EP0249613B1 Interleukin-4 protein having bcgf and tcgf activity on human cells (human interleukin-4) |
07/03/1996 | CN1125946A Novel carbocyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |
07/03/1996 | CN1125942A Substituted beta-aryl and beta-heteroaryl-alpha-cyanoacrylamide derivatives as tyrosine kinase inhibitors |
07/03/1996 | CN1125941A Novel vitamin D analogues |
07/03/1996 | CN1032204C Process for preparing acetylenes disubstituted with phenyl group and heterobicyclic group having retinoid like activity |
07/02/1996 | US5532248 O-aryl,O-alkyl, and O-alkenyl-macrolides having immunosuppressive activity |
07/02/1996 | US5532237 Intraocular for treatment of glaucoma |
07/02/1996 | US5532233 Platelet activating factor antagonist |
07/02/1996 | US5532152 Platelet-activating factor acetylhydrolase |
07/02/1996 | US5530966 Protective garment for baseball umpires having an inner cushioned layer and an outer layer of interconnected plates |
06/27/1996 | WO1996019583A1 Recombinant proteinase from clostridium hystolyticum and the use thereof for isolating cells and cell groups |
06/27/1996 | WO1996019494A1 Peptides having immunomodulatory activity |
06/27/1996 | WO1996019473A1 New derivatives of pyroglutaminic acid, preparation process and applications |
06/27/1996 | WO1996019237A1 Enhanced immunogenic vaccine |
06/27/1996 | WO1996019229A1 Stable solutions of 2-chloro-2'-deoxyadenosine formulations |
06/27/1996 | DE4445891A1 Rekombinante Proteinase aus Clostridium histolyticum und ihre Verwendung zur Isolierung von Zellen und Zellverbänden Recombinant proteinase from Clostridium histolyticum and their use for the isolation of cells and cell aggregates |
06/27/1996 | CA2208431A1 Enhanced immunogenic vaccine |
06/27/1996 | CA2208324A1 Recombinant proteinase from clostridium hystolyticum and the use thereof for isolating cells and cell groups |
06/27/1996 | CA2206778A1 Peptides having immunomodulatory activity |
06/26/1996 | EP0718294A1 2-Amino-1,3-thiazepines and their use as inhibitors of the nitrogene oxide synthase |
06/26/1996 | EP0718286A1 3-Alkoxybenzylpiperidine derivatives as melatonergic agents |
06/26/1996 | EP0717998A1 Use of substance P antagonist for the treatment of pruritis, eye or eyelid pain or disesthesies |
06/26/1996 | EP0717752A1 Therapeutic compounds |
06/26/1996 | EP0717731A1 Difluoro statone antiviral analogs |
06/26/1996 | EP0717633A1 Growth differentiation factor-7 |
06/26/1996 | EP0717632A1 A food additive for improving immunity |
06/26/1996 | EP0717631A1 Immunomodulating compositions from bile |
06/26/1996 | EP0717622A1 Methods of treating hiv with azaspiranes |
06/26/1996 | EP0522001B1 Supportive use of linomide (r) |
06/26/1996 | CN1125442A Imidazole lipoxygenase inhibitors |
06/26/1996 | CN1125436A Vitamin D amide derivatives |
06/26/1996 | CN1125399A Immunogenic cancer proteins and peptides and method of use |
06/26/1996 | CN1125398A Immunomodulatory, anti-inflammatory, and anti-proliferative compounds: 5,6-dideoxy, 5-amino derivatives of idose and 6-deoxy, 6-amino derivatives of glucose |
06/25/1996 | US5530119 Immunosuppressants |
06/25/1996 | US5530101 Humanized immunoglobulins |
06/25/1996 | US5530012 3-alkoxybenzylpiperidine derivatives as melatonergic agents |
06/25/1996 | US5530009 Treating asthma |
06/25/1996 | US5530006 Rapamycin formulation for IV injection |
06/25/1996 | US5529922 Anti-idiotypic monoclonal antibody that induces an immune response against the ganglioside GD3 and hybridoma producing said antibody |